Hip resurfacing for small-sized osteonecrosis: ...
Type de document :
Compte-rendu et recension critique d'ouvrage
PMID :
Titre :
Hip resurfacing for small-sized osteonecrosis: 73 cases at a median 8 years' follow-up.
Auteur(s) :
Martinot, Pierre [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Université Lille Nord (France)
Martinez, Théo [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Université Lille Nord (France)
Dartus, Julien [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Université Lille Nord (France)
Cailliau, Emeline [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Putman, Sophie [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Université Lille Nord (France)
Migaud, Henri [Auteur]
Marrow Adiposity & Bone Lab - Adiposité Médullaire et Os - ULR 4490 [MABLab (ex-pmoi)]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Université Lille Nord (France)
Girard, Julien [Auteur]
Unité de Recherche Pluridisciplinaire Sport, Santé, Société (URePSSS) - ULR 7369 - ULR 4488 [URePSSS]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Université Lille Nord (France)
Martinez, Théo [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Université Lille Nord (France)
Dartus, Julien [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Université Lille Nord (France)
Cailliau, Emeline [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Putman, Sophie [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Université Lille Nord (France)
Migaud, Henri [Auteur]
Marrow Adiposity & Bone Lab - Adiposité Médullaire et Os - ULR 4490 [MABLab (ex-pmoi)]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Université Lille Nord (France)
Girard, Julien [Auteur]
Unité de Recherche Pluridisciplinaire Sport, Santé, Société (URePSSS) - ULR 7369 - ULR 4488 [URePSSS]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Titre de la revue :
Orthopaedics & Traumatology: Surgery & Research
Pagination :
103471
Éditeur :
Elsevier
Date de publication :
2022-11-09
ISSN :
1877-0568
Mot(s)-clé(s) en anglais :
Hip resurfacing
Osteonecrosis of the femoral heads
Ion assay
Osteonecrosis of the femoral heads
Ion assay
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
IntroductionTotal hip resurfacing arthroplasty (THRA) is an alternative to conventional total hip replacement (THR) in young patients with osteonecrosis of the femoral head. Series have been small, without criteria regarding ...
Lire la suite >IntroductionTotal hip resurfacing arthroplasty (THRA) is an alternative to conventional total hip replacement (THR) in young patients with osteonecrosis of the femoral head. Series have been small, without criteria regarding extent of necrosis, thus vitiating results. We therefore conducted a retrospective assessment of THRA for small necrosis, to determine (1) implant survival, (2) functional scores, and (3) systemic chromium, cobalt and titanium ion concentrations.HypothesisThe study hypothesis was that the revision rate is low, meeting the National Institute for Health and Care Excellence (NICE) criterion of < 0.5% revision per year.Material and methodA single-center single-surgeon retrospective study included 62 patients, for 73 RTHAs, with a mean age of 45.6 years (range: 23–68 years) presenting Ficat stage 3 or 4 osteonecrosis of the femoral head with < 330° total Kerboul angle (frontal + lateral angles) on simple preoperative X-ray. Study data comprised implant survival and preoperative and last follow-up functional scores (Postel–Merle–d’Aubigné, Oxford-12, Harris, and Devane) and titanium, chromium and cobalt blood concentrations. Necrosis size was assessed on preoperative Kerboul angle.ResultsAt a median 8 years’ follow-up (IQR: 5.9–9.3 years), implant survival was 98.6% (95% CI: 97.22–99.98%). Only 1 implant was exchanged, for femoral loosening. Three other patients underwent revision surgery: 2 cases of lavage for infection, and 1 muscle hernia repair. Postel–Merle–d’Aubigné, Oxford-12 and Harris functional scores and Devane activity scores were significantly improved at follow-up, by a median +5 (IQR: 5 to 7), −26 (IQR: −29 to −23), +55 (IQR: 49 to 61) and +1 (IQR: 1 to 2), respectively (all p < 0.001). Ion concentrations at last follow-up for titanium, chromium and cobalt were respectively 4.0 μg/L (range: 3.6–4.1), 1.1 μg/L (range: 0.8–1.9) and 1.1 μg/L (range: 0.6–1.8).ConclusionTHRA is a useful option in the long-term for young patients with osteonecrosis with Kerboul angle < 330°.Level of evidenceIV, retrospective study.Lire moins >
Lire la suite >IntroductionTotal hip resurfacing arthroplasty (THRA) is an alternative to conventional total hip replacement (THR) in young patients with osteonecrosis of the femoral head. Series have been small, without criteria regarding extent of necrosis, thus vitiating results. We therefore conducted a retrospective assessment of THRA for small necrosis, to determine (1) implant survival, (2) functional scores, and (3) systemic chromium, cobalt and titanium ion concentrations.HypothesisThe study hypothesis was that the revision rate is low, meeting the National Institute for Health and Care Excellence (NICE) criterion of < 0.5% revision per year.Material and methodA single-center single-surgeon retrospective study included 62 patients, for 73 RTHAs, with a mean age of 45.6 years (range: 23–68 years) presenting Ficat stage 3 or 4 osteonecrosis of the femoral head with < 330° total Kerboul angle (frontal + lateral angles) on simple preoperative X-ray. Study data comprised implant survival and preoperative and last follow-up functional scores (Postel–Merle–d’Aubigné, Oxford-12, Harris, and Devane) and titanium, chromium and cobalt blood concentrations. Necrosis size was assessed on preoperative Kerboul angle.ResultsAt a median 8 years’ follow-up (IQR: 5.9–9.3 years), implant survival was 98.6% (95% CI: 97.22–99.98%). Only 1 implant was exchanged, for femoral loosening. Three other patients underwent revision surgery: 2 cases of lavage for infection, and 1 muscle hernia repair. Postel–Merle–d’Aubigné, Oxford-12 and Harris functional scores and Devane activity scores were significantly improved at follow-up, by a median +5 (IQR: 5 to 7), −26 (IQR: −29 to −23), +55 (IQR: 49 to 61) and +1 (IQR: 1 to 2), respectively (all p < 0.001). Ion concentrations at last follow-up for titanium, chromium and cobalt were respectively 4.0 μg/L (range: 3.6–4.1), 1.1 μg/L (range: 0.8–1.9) and 1.1 μg/L (range: 0.6–1.8).ConclusionTHRA is a useful option in the long-term for young patients with osteonecrosis with Kerboul angle < 330°.Level of evidenceIV, retrospective study.Lire moins >
Langue :
Anglais
Vulgarisation :
Non
Collections :
Source :